WHO ICTRP trial
Colchicine in myocardial infarction
IRCT20220723055534N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20220723055534N1 |
|---|---|
| Public title | Colchicine in myocardial infarction |
| Scientific title | The effect of colchicine on reperfusion arrhythmias in ST-elevation myocardial infarction (STEMI) patients treated with Primary Percutaneous Coronary Intervention (PPCI) |
| Primary sponsor | Qazvin University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Condition 1: ST-elevation myocardial infarction. Condition 2: Cardiac arrhythmia. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Other cardiac arrhythmias |
| Interventions | Intervention 1: Intervention group: STEMI patients who are candidates for PPCI, before PCI, receive 2 grams of colchicine as STAT, and from the second day, 0.5 mg of colchicine will be prescribed every twelve hours for 5 days. Intervention… |
| Registration date | Apr 12, 2023 |
| Target size | 154 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: